Filing Details

Accession Number:
0000059478-22-000086
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-28 16:38:11
Reporting Period:
2022-02-25
Accepted Time:
2022-02-28 16:38:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
59478 Eli Lilly & Co LLY Pharmaceutical Preparations (2834) 350470950
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1561539 A Donald Zakrowski Lilly Corporate Center
Indianapolis IN 46285
Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-02-25 1,660 $243.84 7,274 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,684 Indirect 401(k)
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2021.